315 related articles for article (PubMed ID: 20838203)
1. Disseminated tuberculosis secondary to adalimumab.
Pednekar M; Chandra AB; Chandra PA
Am J Ther; 2012 Jul; 19(4):e139-40. PubMed ID: 20838203
[TBL] [Abstract][Full Text] [Related]
2. Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India -- An audit report.
Malaviya AN; Kapoor S; Garg S; Rawat R; Shankar S; Nagpal S; Khanna D; Furst DE
J Rheumatol; 2009 Jul; 36(7):1414-20. PubMed ID: 19487263
[TBL] [Abstract][Full Text] [Related]
3. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom.
Nisar MK; Rafiq A; Östör AJ
Clin Rheumatol; 2015 Dec; 34(12):2141-5. PubMed ID: 26497501
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.
Carmona L; Gómez-Reino JJ; Rodríguez-Valverde V; Montero D; Pascual-Gómez E; Mola EM; Carreño L; Figueroa M;
Arthritis Rheum; 2005 Jun; 52(6):1766-72. PubMed ID: 15934089
[TBL] [Abstract][Full Text] [Related]
5. Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatments.
Bieber J; Kavanaugh A
Rheum Dis Clin North Am; 2004 May; 30(2):257-70, v. PubMed ID: 15172039
[TBL] [Abstract][Full Text] [Related]
6. Oral tuberculosis in a patient with rheumatoid arthritis after long treatment with methotrexate and adalimumab.
Barouta G; Karapetsa M; Kostopoulou E; Alexiou I; Koukoulis G; Sakkas LI
J Clin Rheumatol; 2010 Oct; 16(7):330-1. PubMed ID: 20859224
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis.
Sichletidis L; Settas L; Spyratos D; Chloros D; Patakas D
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1127-32. PubMed ID: 17044206
[TBL] [Abstract][Full Text] [Related]
8. [The clinical application of quantiferon TB-2G: its usefulness and limitations].
Sato S; Nagai H
Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654
[TBL] [Abstract][Full Text] [Related]
9. Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis.
Murakami S; Takeno M; Kirino Y; Kobayashi M; Watanabe R; Kudo M; Ihata A; Ueda A; Ohno S; Watanuki Y; Kaneko T; Ishigatsubo Y
Tuberculosis (Edinb); 2009 Mar; 89(2):136-41. PubMed ID: 19211305
[TBL] [Abstract][Full Text] [Related]
10. [Two cases of tuberculosis after treatment of rheumatoid arthritis with infliximab].
Takasaka N; Toyota E; Shimada M; Ariga H; Teramoto S; Akagawa S
Nihon Kokyuki Gakkai Zasshi; 2010 Jan; 48(1):60-5. PubMed ID: 20163024
[TBL] [Abstract][Full Text] [Related]
11. National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents.
Doherty SD; Van Voorhees A; Lebwohl MG; Korman NJ; Young MS; Hsu S; National Psoriasis Foundation
J Am Acad Dermatol; 2008 Aug; 59(2):209-17. PubMed ID: 18485527
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-alpha antagonist therapy: safe re-initiation of TNF-alpha blockers after appropriate anti-tuberculous treatment.
Denis B; Lefort A; Flipo RM; Tubach F; Lemann M; Ravaud P; Salmon D; Mariette X; Lortholary O;
Clin Microbiol Infect; 2008 Feb; 14(2):183-6. PubMed ID: 18076664
[TBL] [Abstract][Full Text] [Related]
13. Miliary tuberculosis following negative latent tuberculosis infection screening prior to tumor necrosis factor-α antagonists: implications for management?
Teh BW; Street AC; McBryde ES; Denholm JT
J Rheumatol; 2012 Jun; 39(6):1297-8. PubMed ID: 22661422
[No Abstract] [Full Text] [Related]
14. Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFα inhibitors: the utility of IFNγ assay.
Chen DY; Shen GH; Chen YM; Chen HH; Hsieh CW; Lan JL
Ann Rheum Dis; 2012 Feb; 71(2):231-7. PubMed ID: 22021896
[TBL] [Abstract][Full Text] [Related]
15. Tuberculous pleurisy diagnosed by medical thoracoscopy in an adalimumab-treated rheumatoid arthritis patient after treatment of latent tuberculosis infection.
Nagafuchi Y; Shoda H; Fujio K; Ishii S; Sugiyama H; Yamamoto K
Mod Rheumatol; 2013 Sep; 23(5):1013-7. PubMed ID: 22911136
[TBL] [Abstract][Full Text] [Related]
16. How frequently do tuberculosis screening tests convert in inflammatory bowel disease patients on anti-tumour necrosis factor-alpha? A pilot study.
Bermejo F; Algaba A; Chaparro M; Taxonera C; Garrido E; García-Arata I; Guerra I; Gisbert JP; Olivares D; de-la-Poza G; López-Sanromán A
Dig Liver Dis; 2013 Sep; 45(9):733-7. PubMed ID: 23587496
[TBL] [Abstract][Full Text] [Related]
17. [Immunosuppressive therapy and tuberculosis].
Yoshikawa K; Yano S
Kekkaku; 2010 Jan; 85(1):33-45. PubMed ID: 20232543
[No Abstract] [Full Text] [Related]
18. Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic.
Mor A; Bingham CO; Kishimoto M; Izmirly PM; Greenberg JD; Reddy S; Rosenthal PB
Ann Rheum Dis; 2008 Apr; 67(4):462-5. PubMed ID: 17711866
[TBL] [Abstract][Full Text] [Related]
19. Splenic tuberculosis in a patient with ankylosing spondylitis treated with adalimumab.
Azevedo VF; Paiva E; Tosin T; Ferreira A; Ferreira AM; Fernandes M
Reumatismo; 2011 Nov; 63(3):171-4. PubMed ID: 22257918
[TBL] [Abstract][Full Text] [Related]
20. Primary nasal tuberculosis during anti-tumour necrosis factor alpha treatment of a patient with rheumatoid arthritis.
Ribeiro S; Ferreira B; Duarte R; Almeida I; Vasconcelos C
Scand J Infect Dis; 2013 Dec; 45(12):957-60. PubMed ID: 23957541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
